Business Description
Cellid Co. Ltd. is a South Korean biotechnology company founded in 2006 and based in Seoul, focused on developing vaccines that use the body's immune system to fight cancer and infectious diseases. The company is working on a range of treatments targeting several types of cancer, including cervical, stomach, breast, prostate, and skin cancers, among others. Each treatment is designed to recognize specific markers found on cancer cells, helping the immune system identify and attack them more effectively.
